Share Your Research, Maximize Your Social Impacts
Main Menu
Searching By
PARTNERS
Live -Webinar 2014 - Internet Issues for FDA-Regulated Industry ? A Review of Issues Involving Social Media
Topics/Call fo Papers
DESCRIPTION
Highly-regulated drug, device and other companies subject to FDA’s jurisdiction have embraced using the internet to promote their products. And many have extended their internet strategies to using social media such as Facebook, Twitter, YouTube, Pinterest and even Tumblr to convey their messages. In so doing, however, those firms have encountered an FDA that, in the firms’ minds, is stuck in the 20th century on how it regulates the internet.
This webinar will detail how FDA approaches the regulation of messaging on the Internet, with a particular emphasis on the use of social media. Attendees will learn the agency’s views on the extent of its authority to regulate the internet, with specific examples of firms that have run afoul of FDA’s views on proper internet promotional activities. We also will explore some best practices that firms should adopt to make sure that they stay in FDA’s good graces while taking advantage of these powerful and now not-so-new media outlets. Finally, if published prior to the webinar, we also will explore FDA’s long-awaited guidance document on the internet and social media.
Areas Covered In the Seminar
FDA legal authority over the internet?
Why FDA does not see the internet as needing special rules ? and the absence of agency guidance to date and the potential for guidance to eventually be issued.
When is a web site advertising or labeling or both and why does it matter?
Controls on testimonials and sponsored web and social media sites.
Being careful on what you “like” on social media site regarding your products!
What is “off-label” and whatever happened to the First Amendment?
Who will benefit
Executives (VPs, Directors, Managers) and other professionals involved in implementing the use of social media at FDA-regulated companies. In particular, professionals from these functional arenas:
Sales, Marketing, Quality Assurance, Legal, Regulatory, Compliance, Medical Affairs, Clinical Affairs, Clinical Operations, Investor Relations, Corporate Communications
Free documents/Article/ebooks/sops/checklist for Attendee
Copies of warning letters referred to in presentation will be available following the webinar.
Webinar Includes:
Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
90 Minutes Live Presentation
Certificate of Attendance
Highly-regulated drug, device and other companies subject to FDA’s jurisdiction have embraced using the internet to promote their products. And many have extended their internet strategies to using social media such as Facebook, Twitter, YouTube, Pinterest and even Tumblr to convey their messages. In so doing, however, those firms have encountered an FDA that, in the firms’ minds, is stuck in the 20th century on how it regulates the internet.
This webinar will detail how FDA approaches the regulation of messaging on the Internet, with a particular emphasis on the use of social media. Attendees will learn the agency’s views on the extent of its authority to regulate the internet, with specific examples of firms that have run afoul of FDA’s views on proper internet promotional activities. We also will explore some best practices that firms should adopt to make sure that they stay in FDA’s good graces while taking advantage of these powerful and now not-so-new media outlets. Finally, if published prior to the webinar, we also will explore FDA’s long-awaited guidance document on the internet and social media.
Areas Covered In the Seminar
FDA legal authority over the internet?
Why FDA does not see the internet as needing special rules ? and the absence of agency guidance to date and the potential for guidance to eventually be issued.
When is a web site advertising or labeling or both and why does it matter?
Controls on testimonials and sponsored web and social media sites.
Being careful on what you “like” on social media site regarding your products!
What is “off-label” and whatever happened to the First Amendment?
Who will benefit
Executives (VPs, Directors, Managers) and other professionals involved in implementing the use of social media at FDA-regulated companies. In particular, professionals from these functional arenas:
Sales, Marketing, Quality Assurance, Legal, Regulatory, Compliance, Medical Affairs, Clinical Affairs, Clinical Operations, Investor Relations, Corporate Communications
Free documents/Article/ebooks/sops/checklist for Attendee
Copies of warning letters referred to in presentation will be available following the webinar.
Webinar Includes:
Q/A Session with the Expert to ask your question
PDF print only copy of PowerPoint slides
90 Minutes Live Presentation
Certificate of Attendance
Other CFPs
- Bioterrorism and Food Security-A Cultural Conundrum
- US, EU and Japan GMP Requirements: Practical ICH Area Differences, Healthcare Authority Inspection Focus
- 21 CFR Part 820 Quality System Regulation - Applying Principles of Lean Documents and Lean Configuration
- Patient Rights and the HIPAA Privacy Officer - Meeting Patient Desires and Avoiding Penalties
- Medical Devices: EU Directives, Guidance Documents, CE Marking Process and ISO Certification Programs
Last modified: 2014-10-14 13:38:03